Annovis Bio Inc (ANVS)

01:33 AM

Annovis Bio, Inc.(NYSE: ANVS) added to Russell Microcap Index - marketscreener.com

01:33 AM

Jun 27, 2026

Annovis Bio | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Jun 27, 2026

Jun 26, 2026

Annovis Bio | DEFA14A: Others - Moomoo

Jun 26, 2026

Jun 26, 2026

ANVS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

Annovis Bio Inc Actuals & Estimates (FWB:07X) - TradingView

Jun 26, 2026

Jun 26, 2026

07X Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBITDA forward of Annovis Bio, Inc. – NYSE:ANVS - TradingView

Jun 25, 2026

Jun 25, 2026

Price to sales forward of Annovis Bio, Inc. – NYSE:ANVS - TradingView

Jun 25, 2026

Jun 25, 2026

Enterprise value to revenue forward of Annovis Bio, Inc. – NYSE:ANVS - TradingView

Jun 25, 2026

Jun 21, 2026

Annovis Bio Inc (ANVS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 21, 2026

Jun 18, 2026

Annovis Bio Shareholders Approve Governance and Compensation Changes - The Globe and Mail

Jun 18, 2026

Jun 18, 2026

Why Annovis’ buntanetap pill is drawing fresh attention in Alzheimer’s race - Ad-hoc-news.de

Jun 18, 2026

Jun 18, 2026

Annovis Bio Inc (ANVS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026

Jun 18, 2026

Annovis Bio shareholders approve all proposals at annual meeting By Investing.com - Investing.com Australia

Jun 18, 2026

Jun 17, 2026

Annovis Bio shareholders approve all proposals at annual meeting - Investing.com UK

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio (NYSE: ANVS) holders expand equity plan and set biennial say-on-pay - Stock Titan

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Annovis Bio Inc (ANVS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 14, 2026

Press Release: Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - 富途牛牛

Jun 14, 2026

Jun 10, 2026

Annovis Bio Inc Stock (US0360431013): Short Interest Climbs At End Of May - AD HOC NEWS

Jun 10, 2026

Jun 05, 2026

Annovis Bio Price, ANVS Price, Live Charts, and Marketcap - Coinbase

Jun 05, 2026

Jun 03, 2026

Annovis Regains NYSE Compliance Ahead of Listing Deadline - MyChesCo

Jun 03, 2026

May 29, 2026

Maxim Group Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 29, 2026

May 26, 2026

Annovis Bio (ANVS) Faces Selling Pressure: Key Levels in Focus After 7.6% DeclineVolume Rate Change - thelegaladvocate.com

May 26, 2026

May 26, 2026

Annovis Bio regains NYSE listing compliance - MSN

May 26, 2026

May 26, 2026

Annovis Bio regains NYSE listing compliance By Investing.com - Investing.com Nigeria

May 26, 2026

May 26, 2026

Annovis Bio Regains NYSE Listing Compliance - The Manila Times

May 26, 2026

May 23, 2026

Annovis launches proposed public stock and warrant offering - MSN

May 23, 2026

May 22, 2026

Annovis Bio Analyst Ratings and Price Targets | NYSE:ANVS - Benzinga

May 22, 2026

May 22, 2026

Annovis Bio director Michael Hoffman buys $142,778 in shares By Investing.com - Investing.com Nigeria

May 22, 2026

May 21, 2026

Annovis Bio director Michael Hoffman buys $142,778 in shares - Investing.com UK

May 21, 2026

May 21, 2026

3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced - Moomoo

May 21, 2026

May 21, 2026

Annovis Bio (ANVS) Rebounds 5.39%, Tests Key Resistance After Broader Market Upward MomentumCorrective Wave - thelegaladvocate.com

May 21, 2026

May 21, 2026

Director Michael Hoffman adds 76,344 Annovis Bio (ANVS) shares in open-market buys - Stock Titan

May 21, 2026

May 20, 2026

Annovis Bio prices $15 million public offering at $1.90 - Investing.com UK

May 20, 2026

May 20, 2026

Annovis Bio Announces Dilutive Equity Offering for Trials - TipRanks

May 20, 2026

May 20, 2026

Annovis Bio Launches ~$15 Million Stock-and-Warrant Offering Underwritten by Canaccord Genuity - TradingView

May 20, 2026